NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Trial Required)
ID: 348404Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/348404

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-201.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the NEI Collaborative Clinical Vision Research Project: Resource Center Grant (NOFO PAR-23-201), aimed at supporting large-scale clinical trials and complex vision research. This funding opportunity focuses on evaluating interventions for screening, diagnosing, preventing, or treating vision disorders, and will provide essential services such as imaging and laboratory capabilities for multi-center clinical trials of significant public health importance. The initiative encourages participation from a diverse range of eligible organizations, including higher education institutions and non-profits, particularly those representing underrepresented racial and ethnic groups. Applications are due by 5 PM local time on May 25, 2026, and interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-201.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-201-Full-Announcement.html
    PAR-23-201.html
    The National Eye Institute (NEI) is seeking applications for the NEI Collaborative Clinical Vision Research Project: Resource Center Grant (NOFO PAR-23-201). This funding opportunity aims to facilitate large-scale clinical trials and complex vision research, specifically those evaluating interventions in screening, diagnosing, preventing, or treating vision disorders. The Resource Center Grant will support requisite services, including imaging and laboratory capabilities, for multi-center clinical trials of high public health significance. Eligible organizations include higher education institutions, non-profits, and government entities, with particular encouragement for those from diverse backgrounds, including underrepresented racial and ethnic groups. Application submissions are due by 5 PM local time on specified due dates, with projected awards contingent upon appropriations. The funding encourages innovative clinical trials while emphasizing adherence to newly instituted data management policies and sharing plans, effective from January 25, 2023. This initiative illustrates NEI's commitment to advancing vision research through collaboration and robust oversight, ensuring high standards of scientific rigor and participant safety throughout the research process.
    Similar Opportunities
    NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the NEI Collaborative Clinical Vision Research Project, specifically seeking applications for a Coordinating Center grant under the UG1 activity code. This initiative aims to support large-scale, investigator-initiated clinical trials focused on vision disorders, including interventions for screening, diagnosing, preventing, or treating these conditions, with an emphasis on projects that require significant oversight and management. The NEI's mission is to advance vision research and enhance public health through rigorous clinical trials, ensuring compliance with NIH policies and ethical standards in research involving human subjects. Interested applicants, including a diverse range of organizations such as higher education institutions and nonprofits, must submit their applications by May 25, 2026, and can find further details at the provided NIH grants information email: grantsinfo@nih.gov.
    NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NEI Center Core Grant for Vision Research, aimed at enhancing collaborative vision research through shared resource and service cores for funded investigators. This grant supports institutions with eight or more active NEI-supported R01 grants, providing direct costs of up to $2 million or $2.5 million over five years, depending on the number of eligible grants at the institution. The program is designed to increase productivity and collaboration among researchers while offering high-quality services that would be too costly for individual projects, ultimately supporting the NEI's mission to advance understanding of vision disorders. Applications are due by September 30, 2023, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Eye Institute (NEI), has announced a Notice of Funding Opportunity (NOFO) for the NEI Collaborative Clinical Vision Research: Chair's Grant (UG1), aimed at supporting large-scale clinical trials focused on vision disorders. This funding opportunity is intended for projects that evaluate interventions for screening, diagnosing, preventing, or treating vision disorders, specifically requiring a clinical trial with a clear scientific rationale and detailed study design. The NEI emphasizes the importance of these trials in advancing vision science and public health, with awards structured as cooperative agreements to ensure substantial NIH involvement in the research process. Interested applicants must submit their proposals by May 25, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Eye Institute (NEI) for cooperative agreements (U01) aimed at supporting early-stage clinical trials that involve greater than minimal risk, specifically targeting interventions for vision disorders. This initiative encourages applications for Phase I or II trials that are backed by strong preliminary data and require compliance with NIH guidelines, including the establishment of a Data Monitoring and Safety Committee (DSMC) for safety oversight. The funding is crucial for advancing research in the screening, diagnosis, prevention, and treatment of vision disorders, with project budgets reflecting actual needs and a maximum project period of five years. Interested applicants can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with the application deadline set for May 7, 2025.
    NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Eye Institute (NEI), is inviting applications for the NEI Research Grant for Vision-Related Secondary Data Analysis (R21), which focuses on funding innovative research projects that utilize existing vision-related datasets for secondary data analyses. This opportunity aims to enhance understanding of vision health issues by encouraging researchers to leverage data from previous clinical trials or epidemiologic studies, while explicitly excluding support for new data collection. Eligible applicants include a wide range of institutions, such as historically black colleges and universities, tribal colleges, and community-based organizations, with a direct cost ceiling of $275,000 for projects lasting up to two years. Interested parties should submit their applications by May 7, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.
    NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI Clinical Research Study Planning Grant Program (R34), aimed at supporting the development of clinical trial protocols and procedures specifically for eye and vision-related studies. This grant facilitates the preparation of a comprehensive Manual of Procedures (MOP) and allows for preliminary studies to assess recruitment potential, without generating data on intervention effects. Grants may provide up to $150,000 per year for a maximum of two years, with applications due by May 7, 2025. Eligible applicants include a wide range of institutions, including educational, nonprofit, and government entities, and inquiries can be directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled the NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) aimed at accelerating the translation of innovative laboratory research into therapeutic interventions for visual system diseases. This program employs a bi-phasic, milestone-driven mechanism consisting of an Exploratory (R61) phase lasting up to two years and a Developmental (R33) phase lasting up to three years, focusing on generating preclinical data that supports applications for Investigational New Drug (IND) or Investigational Device Exemption (IDE) submissions to the FDA. The initiative is designed to engage diverse organizations, including historically black colleges, tribal governments, and community-based organizations, to foster collaborative efforts in ocular research, ultimately improving health outcomes through vision research. Interested applicants can find more information and guidelines at the provided link, with a funding ceiling of $500,000 and a submission deadline of March 16, 2025.
    NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI Regenerative Medicine Clinical Trial Planning Grant (R34) to support the development of clinical trial protocols aimed at restoring vision through cell regeneration. This grant is designed to fund essential activities such as creating a Manual of Procedures (MOP), obtaining regulatory approvals, and assessing the feasibility of clinical trials that involve regenerative strategies, particularly those utilizing stem cells. The initiative underscores the federal commitment to advancing vision restoration research, with a funding ceiling of $150,000 per year for projects lasting up to two years. Interested applicants, including various educational institutions and organizations, must adhere to strict submission guidelines via Grants.gov, with applications due by May 7, 2025. For further inquiries, applicants can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NEI Postbaccalaureate Opportunities in Vision Science (POVS) Research Education Program (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI Postbaccalaureate Opportunities in Vision Science (POVS) Research Education Program, a federal grant aimed at enhancing diversity in biomedical research through hands-on research experiences for recent college graduates from underrepresented backgrounds. This program supports educational activities that prepare participants for doctoral programs in biomedical fields, with a specific focus on vision science research, mentorship, and fostering an inclusive research environment. The maximum funding amount is $400,000 per project, with a project duration of up to five years, and applications are due by January 25, 2027. For more information, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-290.html.
    NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NEI Translational Research Program for Therapeutics, aimed at accelerating the translation of innovative laboratory research into therapeutics for visual system diseases. This program seeks to fund multidisciplinary teams that can generate preclinical data leading to Investigational New Drug (IND) or Investigational Device Exemption (IDE) applications, with a focus on developing biological, pharmacological, and medical device interventions. The initiative underscores the federal commitment to translating biomedical research into practical therapies, ultimately enhancing patient care in ocular health. Grants of up to $1 million per year are available, with applications due by March 16, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.